In summary, this study takes the lead in finding that IL-4 is associated with immunotherapy resistance in gastric cancer, and to reveal the molecular mechanism of the metabolic reprogramming of macrophages mediated by IL-4. This evidence concerns the gene IL4 and gastric cancer.